Literature DB >> 17904691

Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies.

Ivana Lula1, Angelo L Denadai, Jarbas M Resende, Frederico B de Sousa, Guilherme F de Lima, Dorila Pilo-Veloso, Thomas Heine, Hélio A Duarte, Robson A S Santos, Rubén D Sinisterra.   

Abstract

We report the complete sequence-specific hydrogen NMR assignments of vasoactive peptide angiotensin-(1-7) (Ang-(1-7)). Assignments of the majority of the resonances were accomplished by COSY, TOCSY, and ROESY peak coordinates at 400MHz and 600MHz. Long-side-chain amino acid spin system identification was facilitated by long-range coherence transfer experiments (TOCSY). Problems with overlapped resonance signals were solved by analysis of heteronuclear 2D experiments (HSQC and HMBC). Nuclear Overhauser effects (NOE) results were used to probe peptide conformation. We show that the inclusion of the angiotensin-(1-7) tyrosine residue is favored in inclusion complexes with beta-cyclodextrin. QM/MM simulations at the DFTB/UFF level confirm the experimental NMR findings and provide detailed structural information on these compounds in aqueous solution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904691     DOI: 10.1016/j.peptides.2007.08.011

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  22 in total

1.  Structural libraries of protein models for multiple species to understand evolution of the renin-angiotensin system.

Authors:  Jeremy W Prokop; Victoria Petri; Mary E Shimoyama; Ingrid K M Watanabe; Dulce E Casarini; Thomas C Leeper; Stephanie M Bilinovich; Howard J Jacob; Robson A S Santos; Almir S Martins; Fabiano C Araujo; Fernando M Reis; Amy Milsted
Journal:  Gen Comp Endocrinol       Date:  2014-09-26       Impact factor: 2.822

2.  Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.

Authors:  Rasna Sabharwal; Michael Z Cicha; Ruben D M Sinisterra; Frederico B De Sousa; Robson A Santos; Mark W Chapleau
Journal:  Clin Sci (Lond)       Date:  2014-07       Impact factor: 6.124

Review 3.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.

Authors:  Rodrigo Araujo Fraga-Silva; Anderson Jose Ferreira; Robson Augusto Souza Dos Santos
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 6.  Are we poised to target ACE2 for the next generation of antihypertensives?

Authors:  Anderson J Ferreira; Mohan K Raizada
Journal:  J Mol Med (Berl)       Date:  2008-05-01       Impact factor: 4.599

7.  Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?

Authors:  Ranjit Singh Padda; Yixuan Shi; Chao-Sheng Lo; Shao-Ling Zhang; John S D Chan
Journal:  J Diabetes Metab       Date:  2015-10-14

8.  Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats.

Authors:  Sérgio H S Santos; Jorge F Giani; Valeria Burghi; Johanna G Miquet; Fatimunnisa Qadri; Janaina F Braga; Mihail Todiras; Katarina Kotnik; Natalia Alenina; Fernando P Dominici; Robson A S Santos; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2013-10-27       Impact factor: 4.599

Review 9.  ACE2, angiotensin-(1–7), and Mas: the other side of the coin.

Authors:  Michael Bader
Journal:  Pflugers Arch       Date:  2013-01       Impact factor: 3.657

Review 10.  Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.

Authors:  Anderson J Ferreira; Robson A S Santos; Chastity N Bradford; Adam P Mecca; Colin Sumners; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.